Related Experiment Video

Updated: Jun 15, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Development of potential antiviral strategy against coxsackievirus B4

Eng Lee Tan1, Andrew Phui Yew Wong, Chit Laa Poh

  • 1School of Chemical and Life Sciences, Biomedical Science Section, Singapore Polytechnic, 500 Dover Road, Singapore.

Virus Research
|March 11, 2010
PubMed

Insights

RNA interference (RNAi) using small interfering RNAs (siRNAs) effectively inhibits Coxsackievirus B4 (CVB4) replication. Targeting the 3C protease region showed the most promise for developing new antiviral therapies against CVB4 infections.

Area of Science:

  • Virology
  • Molecular Biology
  • Therapeutics

Background:

  • Coxsackievirus B4 (CVB4) is associated with severe neonatal diseases and potentially type 1 diabetes.
  • Current therapeutic strategies for CVB4 infections are limited.
  • RNA interference (RNAi) presents a potential novel therapeutic avenue.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) as a therapeutic strategy against Coxsackievirus B4 (CVB4).
  • To identify specific small interfering RNAs (siRNAs) effective in inhibiting CVB4 replication.
  • To evaluate the specificity and potential of siRNA-based therapy for CVB4 infections.

Main Methods:

  • Treatment of Rhabdomyosarcoma (RD) cells with 19-mer siRNAs targeting the CVB4 genome.
  • Assessment of siRNA specificity and antiviral effects on CVB4 replication.
  • Evaluation of siRNA dosage-dependent inhibition of CVB4 replication, focusing on the 3C(pro) region.

Main Results:

  • siRNAs demonstrated high specificity against CVB4 replication in RD cells.
  • No off-target effects were observed in the treated cells.
  • siRNA targeting the CVB4 3C(pro) region proved most effective in inhibiting viral replication.
  • Inhibition was observed in a dose-dependent manner.

Conclusions:

  • RNA interference (RNAi) is a highly specific and effective approach for inhibiting Coxsackievirus B4 (CVB4) replication.
  • Targeting the 3C(pro) region of the CVB4 genome with siRNA offers a promising strategy for developing novel antiviral treatments.
  • Further development of siRNA-based therapies could provide a new therapeutic option for CVB4 infections.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Assays for the Identification of Novel Antivirals against Bluetongue Virus12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...